Pesquisas alternativas:
"caso open" » "case open" (Expandir a Pesquisa), "caso lopez" (Expandir a Pesquisa), "cases open" (Expandir a Pesquisa), "cado open" (Expandir a Pesquisa), "caao open" (Expandir a Pesquisa), "cao open" (Expandir a Pesquisa)
"ecmo en" » "ecmo run" (Expandir a Pesquisa), "ecmo can" (Expandir a Pesquisa), "ecmo new" (Expandir a Pesquisa)
"o opens" » "_ opens" (Expandir a Pesquisa), "1 opens" (Expandir a Pesquisa), "2 opens" (Expandir a Pesquisa)
"so open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "o open" (Expandir a Pesquisa)
"esmo open" » "esto open" (Expandir a Pesquisa), "eso open" (Expandir a Pesquisa)
A mostrar 341 - 360 resultados de 988 para a pesquisa '(((((("esmo open") OR ("ecmo en"))) OR ("o opens"))) OR ((("so open") OR ("caso open"))))', tempo de pesquisa: 3.54seg Refinar resultados
Emerging challenges of advanced squamous cell lung cancer
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
Immunotherapy for hepatocellular carcinoma: current status and future perspectives

Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
Aurora kinases in ovarian cancer

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer
Prevention of venous thromboembolism in ambulatory patients with cancer

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association
How we treat locoregional melanoma

Emerging targets for anticancer vaccination: IDH
Cancer in pregnancy: disentangling treatment modalities

Renal insufficiency and cancer treatments
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example
ASCO highlights podcast: head and neck cancers

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
Critically ill patients with cancer: chances and limitations of intensive care medicine—a narrative review

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa